Pulmonary surfactant is a mixture of phospholipids and proteins synthesized in alveolar type-II cells that is necessary for maintaining alveolar expansion at end-expiration. Phospholipids comprise ...
Preclinical studies suggest that exogenous surfactant may be of value in the treatment of the acute respiratory distress syndrome (ARDS), and two phase 2 clinical trials have shown a trend toward ...
In a recent study posted to the bioRxiv* preprint server, researchers discuss the role of a surfactant-mediated inflammatory response employed by human lungs against the severe acute respiratory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results